BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24556084)

  • 21. Merosin-deficient congenital muscular dystrophy and cortical dysplasia.
    Brett FM; Costigan D; Farrell MA; Heaphy P; Thornton J; King MD
    Eur J Paediatr Neurol; 1998; 2(2):77-82. PubMed ID: 10724100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Merosin-positive congenital muscular dystrophy with mental retardation, microcephaly and central nervous system abnormalities unlinked to the Fukuyama muscular dystrophy and muscular-eye-brain loci: report of three siblings.
    Ruggieri V; Lubieniecki F; Meli F; Diaz D; Ferragut E; Saito K; Brockington M; Muntoni F; Fukuyama Y; Taratuto AL
    Neuromuscul Disord; 2001 Sep; 11(6-7):570-8. PubMed ID: 11525887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary reduction of alpha7B integrin in laminin alpha2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle.
    Cohn RD; Mayer U; Saher G; Herrmann R; van der Flier A; Sonnenberg A; Sorokin L; Voit T
    J Neurol Sci; 1999 Mar; 163(2):140-52. PubMed ID: 10371075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Congenital muscular dystrophy with secondary merosin deficiency and normal brain MRI: a novel entity?
    Mercuri E; Sewry CA; Brown SC; Brockington M; Jungbluth H; DeVile C; Counsell S; Manzur A; Muntoni F
    Neuropediatrics; 2000 Aug; 31(4):186-9. PubMed ID: 11071142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Muscular dystrophies due to alterations at extracellular space level: congenital muscular dystrophy caused by merosin deficiency].
    Smeyers P
    Rev Neurol; 1999 Jan 16-31; 28(2):141-9. PubMed ID: 10101782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Non-Fukuyama type congenital muscular dystrophy--merosin deficient and positive forms].
    Nonaka I
    Nihon Rinsho; 1997 Dec; 55(12):3176-80. PubMed ID: 9436431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Congenital muscular dystrophy with primary laminin alpha2 (merosin) deficiency presenting as inflammatory myopathy.
    Pegoraro E; Mancias P; Swerdlow SH; Raikow RB; Garcia C; Marks H; Crawford T; Carver V; Di Cianno B; Hoffman EP
    Ann Neurol; 1996 Nov; 40(5):782-91. PubMed ID: 8957020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis and etiology of congenital muscular dystrophy.
    Peat RA; Smith JM; Compton AG; Baker NL; Pace RA; Burkin DJ; Kaufman SJ; Lamandé SR; North KN
    Neurology; 2008 Jul; 71(5):312-21. PubMed ID: 18160674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further evidence for POMK as candidate gene for WWS with meningoencephalocele.
    Paul L; Rupprich K; Della Marina A; Stein A; Elgizouli M; Kaiser FJ; Schweiger B; Köninger A; Iannaccone A; Hehr U; Kölbel H; Roos A; Schara-Schmidt U; Kuechler A
    Orphanet J Rare Dis; 2020 Sep; 15(1):242. PubMed ID: 32907597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Congenital muscular dystrophy with laminin alpha 2 chain deficiency: identification of a new intermediate phenotype and correlation of clinical findings to muscle immunohistochemistry.
    Herrmann R; Straub V; Meyer K; Kahn T; Wagner M; Voit T
    Eur J Pediatr; 1996 Nov; 155(11):968-76. PubMed ID: 8911899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel homozygous ISPD gene mutation causing phenotype variability in a consanguineous family.
    Baranello G; Saredi S; Sansanelli S; Savadori P; Canioni E; Chiapparini L; Balestri P; Malandrini A; Arnoldi MT; Pantaleoni C; Morandi L; Mora M
    Neuromuscul Disord; 2015 Jan; 25(1):55-9. PubMed ID: 25444434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Profound skeletal muscle depletion of alpha-dystroglycan in Walker-Warburg syndrome.
    Jiménez-Mallebrera C; Torelli S; Brown SC; Feng L; Brockington M; Sewry CA; Beltrán-Valero De Bernabé D; Muntoni F
    Eur J Paediatr Neurol; 2003; 7(3):129-37. PubMed ID: 12788039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dystrophin-glycoproteins associated in congenital muscular dystrophy: immunohistochemical analysis of 59 Brazilian cases.
    Ferreira LG; Marie SK; Liu EC; Resende MB; Carvalho MS; Scaff M; Reed UC
    Arq Neuropsiquiatr; 2005 Sep; 63(3B):791-800. PubMed ID: 16258658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variable clinical phenotype in merosin-deficient congenital muscular dystrophy associated with differential immunolabelling of two fragments of the laminin alpha 2 chain.
    Sewry CA; Naom I; D'Alessandro M; Sorokin L; Bruno S; Wilson LA; Dubowitz V; Muntoni F
    Neuromuscul Disord; 1997 May; 7(3):169-75. PubMed ID: 9185180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Congenital muscular dystrophy with muscle inflammation alpha dystroglycan glycosylation defect and no mutation in FKRP gene.
    Lamperti C; Cagliani R; Ciscato P; Moroni I; Viri M; Romeo A; Fagiolari G; Prelle A; Comi GP; Bresolin N; Moggio M
    J Neurol Sci; 2006 Apr; 243(1-2):47-51. PubMed ID: 16386759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B3GALNT2 mutations associated with non-syndromic autosomal recessive intellectual disability reveal a lack of genotype-phenotype associations in the muscular dystrophy-dystroglycanopathies.
    Maroofian R; Riemersma M; Jae LT; Zhianabed N; Willemsen MH; Wissink-Lindhout WM; Willemsen MA; de Brouwer APM; Mehrjardi MYV; Ashrafi MR; Kusters B; Kleefstra T; Jamshidi Y; Nasseri M; Pfundt R; Brummelkamp TR; Abbaszadegan MR; Lefeber DJ; van Bokhoven H
    Genome Med; 2017 Dec; 9(1):118. PubMed ID: 29273094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Merosin-negative congenital muscular dystrophy associated with extensive brain abnormalities.
    Sunada Y; Edgar TS; Lotz BP; Rust RS; Campbell KP
    Neurology; 1995 Nov; 45(11):2084-9. PubMed ID: 7501163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral nerve involvement in merosin-deficient congenital muscular dystrophy and dy mouse.
    Matsumura K; Yamada H; Saito F; Sunada Y; Shimizu T
    Neuromuscul Disord; 1997 Jan; 7(1):7-12. PubMed ID: 9132144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laminin-alpha2 (merosin), beta-dystroglycan, alpha-sarcoglycan (adhalin), and dystrophin expression in congenital muscular dystrophies: an immunohistochemical study.
    ter Laak HJ; Leyten QH; Gabreëls FJ; Kuppen H; Renier WO; Sengers RC
    Clin Neurol Neurosurg; 1998 Mar; 100(1):5-10. PubMed ID: 9637197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Merosin-positive congenital muscular dystrophy in two siblings with cataract and slight mental retardation.
    Reed UC; Tsanaclis AM; Vainzof M; Marie SK; Carvalho MS; Roizenblatt J; Pedreira CC; Diament A; Levy JA
    Brain Dev; 1999 Jun; 21(4):274-8. PubMed ID: 10392752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.